Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology
- 21 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (20) , 2337-2340
- https://doi.org/10.1161/01.cir.0000018444.47798.94
Abstract
Background — Autosomal dominant hypertrophic cardiomyopathy (HCM) is caused by inherited defects of sarcomeric proteins. We tested the hypothesis that homozygosity for a sarcomeric protein defect can cause recessive HCM. Methods and Results — We studied a family with early-onset cardiomyopathy in 3 siblings, characterized by mid-cavitary hypertrophy and restrictive physiology. Genotyping of DNA markers spanning 8 genes for autosomal dominant HCM revealed inheritance of an identical paternal and maternal haplotype at the essential light chain of myosin locus by the affected children. Sequencing showed that these individuals were homozygous for a Glu143Lys substitution of a highly conserved amino acid that was absent in 150 controls. Family members with one Glu143Lys allele had normal echocardiograms and ECGs, even in late adulthood, whereas those with two mutant alleles developed severe cardiomyopathy in childhood. These findings, coupled with previous studies of myosin light chain structure and function in the heart, suggest a loss-of-function disease mechanism. Conclusions — Distinct mutations affecting the same sarcomeric protein can cause either dominant or recessive cardiomyopathy. Electrostatic charge reversal of a highly conserved amino acid may be benign in the heterozygous state as the result of compensatory mechanisms that preserve cardiac structure and function. By contrast, homozygous carriers of a sarcomeric protein defect may have a malignant course. Recognizing recessive inheritance in children with cardiomyopathy is essential for appropriate family counseling.Keywords
This publication has 16 references indexed in Scilit:
- Inherited and de novo Mutations in the Cardiac Actin Gene Cause Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- Functional significance of cardiac myosin essential light chain isoform switching in transgenic mice.Journal of Clinical Investigation, 1998
- A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genesHuman Genetics, 1998
- Substitution Mutations in the Myosin Essential Light Chain Lead to Reduced Actin-activated ATPase Activity Despite Stoichiometric Binding to the Heavy ChainPublished by Elsevier ,1997
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleNature Genetics, 1996
- Mapping a cardiomyopathy locus to chromosome 3p22-p25.Journal of Clinical Investigation, 1996
- Possible Gene Effect of a Mutant Cardiac β-Myosin Heavy Chain Gene on the Clinical Expression of Familial Hypertrophic CardiomyopathyBiochemical and Biophysical Research Communications, 1994
- Skeletal muscle myosin light chains are essential for physiological speeds of shorteningNature, 1993
- Structure of the actin-myosin complex and its implications for muscle contractionScience, 1993